Jiabin An

1.3k total citations
20 papers, 1.1k citations indexed

About

Jiabin An is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jiabin An has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Jiabin An's work include NF-κB Signaling Pathways (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Viral-associated cancers and disorders (4 papers). Jiabin An is often cited by papers focused on NF-κB Signaling Pathways (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Viral-associated cancers and disorders (4 papers). Jiabin An collaborates with scholars based in United States, China and Sweden. Jiabin An's co-authors include Matthew B. Rettig, Yiping Sun, Myrna Fisher, Huiren Liu, Allan J. Pantuck, Ren Sun, Alan Lichtenstein, Gregory A. Brent, Eri S. Srivatsan and Mysore S. Veena and has published in prestigious journals such as Nucleic Acids Research, Blood and Molecular and Cellular Biology.

In The Last Decade

Jiabin An

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiabin An United States 17 530 428 348 211 189 20 1.1k
J Faivre France 20 379 0.7× 537 1.3× 166 0.5× 132 0.6× 177 0.9× 90 1.3k
Martin Schneider Germany 20 530 1.0× 474 1.1× 300 0.9× 124 0.6× 217 1.1× 45 1.2k
Gauri C. Bedi United States 8 942 1.8× 877 2.0× 485 1.4× 101 0.5× 180 1.0× 8 1.7k
Huan Yan China 21 763 1.4× 209 0.5× 302 0.9× 110 0.5× 176 0.9× 38 1.3k
Yaqin He China 15 978 1.8× 459 1.1× 294 0.8× 267 1.3× 196 1.0× 22 1.5k
Steve F. Bronk United States 16 769 1.5× 337 0.8× 388 1.1× 439 2.1× 207 1.1× 18 1.6k
Nyree Crawford United Kingdom 21 889 1.7× 405 0.9× 189 0.5× 104 0.5× 173 0.9× 34 1.2k
Lydie Gioia‐Patricola France 16 576 1.1× 365 0.9× 283 0.8× 94 0.4× 211 1.1× 18 1.1k
Manujendra N. Saha Canada 20 610 1.2× 333 0.8× 185 0.5× 61 0.3× 145 0.8× 32 1.1k
Zhi Ming Shao China 15 806 1.5× 776 1.8× 411 1.2× 67 0.3× 73 0.4× 22 1.4k

Countries citing papers authored by Jiabin An

Since Specialization
Citations

This map shows the geographic impact of Jiabin An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiabin An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiabin An more than expected).

Fields of papers citing papers by Jiabin An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiabin An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiabin An. The network helps show where Jiabin An may publish in the future.

Co-authorship network of co-authors of Jiabin An

This figure shows the co-authorship network connecting the top 25 collaborators of Jiabin An. A scholar is included among the top collaborators of Jiabin An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiabin An. Jiabin An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
An, Jiabin, et al.. (2025). Research on Screening Method of Loess Slope Stability Evaluation Indexes Based on Validity and Reliability Coefficient. Applied Sciences. 15(11). 6216–6216. 1 indexed citations
2.
An, Jiabin, Yanchuan Guo, Ting Wang, Allan J. Pantuck, & Matthew B. Rettig. (2015). Pomegranate extract inhibits EMT in clear cell renal cell carcinoma in a NF-κB and JNK dependent manner. Asian journal of urology. 2(1). 38–45. 11 indexed citations
3.
An, Jiabin, Huiren Liu, Clara E. Magyar, et al.. (2013). Hyperactivated JNK Is a Therapeutic Target in pVHL-Deficient Renal Cell Carcinoma. Cancer Research. 73(4). 1374–1385. 45 indexed citations
4.
Pantuck, Allan J., Jiabin An, Huiren Liu, & Matthew B. Rettig. (2010). NF-κB–Dependent Plasticity of the Epithelial to Mesenchymal Transition Induced by Von Hippel-Lindau Inactivation in Renal Cell Carcinomas. Cancer Research. 70(2). 752–761. 77 indexed citations
5.
An, Jiabin, et al.. (2010). p120-Catenin Is Transcriptionally Downregulated by FOXC2 in Non–Small Cell Lung Cancer Cells. Molecular Cancer Research. 8(5). 762–774. 45 indexed citations
6.
An, Jiabin, Huiren Liu, Mysore S. Veena, et al.. (2008). Inactivation of the CYLD Deubiquitinase by HPV E6 Mediates Hypoxia-Induced NF-κB Activation. Cancer Cell. 14(5). 394–407. 86 indexed citations
7.
Rettig, Matthew B., David Heber, Jiabin An, et al.. (2008). Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-κB-dependent mechanism. Molecular Cancer Therapeutics. 7(9). 2662–2671. 102 indexed citations
8.
An, Jiabin & Matthew B. Rettig. (2007). Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib. Molecular Cancer Therapeutics. 6(1). 61–69. 43 indexed citations
9.
Ying, Alice, et al.. (2005). Engineering Scaling Requirements for Solid Breeder Blanket Testing. Fusion Science & Technology. 47(4). 1031–1037. 4 indexed citations
10.
An, Jiabin & Matthew B. Rettig. (2005). Mechanism of von Hippel-Lindau Protein-Mediated Suppression of Nuclear Factor kappa B Activity. Molecular and Cellular Biology. 25(17). 7546–7556. 87 indexed citations
11.
An, Jiabin, Myrna Fisher, & Matthew B. Rettig. (2004). VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-κB-dependent mechanism. Oncogene. 24(9). 1563–1570. 47 indexed citations
12.
An, Jiabin, et al.. (2004). Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas. Leukemia. 18(10). 1699–1704. 68 indexed citations
13.
An, Jiabin, Yiping Sun, Myrna Fisher, & Matthew B. Rettig. (2004). Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-κB dependent. Molecular Cancer Therapeutics. 3(6). 727–736. 49 indexed citations
14.
An, Jiabin, Yiping Sun, Myrna Fisher, & Matthew B. Rettig. (2004). Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-kappaB dependent.. PubMed. 3(6). 727–36. 59 indexed citations
15.
An, Jiabin, Yiping Sun, Ren Sun, & Matthew B. Rettig. (2003). Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-κB and JNK/AP1 pathways. Oncogene. 22(22). 3371–3385. 103 indexed citations
16.
An, Jiabin, Yiping Sun, & Matthew B. Rettig. (2003). Transcriptional coactivation of c-Jun by the KSHV-encoded LANA. Blood. 103(1). 222–228. 46 indexed citations
17.
An, Jiabin, Yiping Sun, Julian Adams, et al.. (2003). Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancer.. PubMed. 9(12). 4537–45. 45 indexed citations
18.
An, Jiabin, Alan Lichtenstein, Gregory A. Brent, & Matthew B. Rettig. (2002). The Kaposi sarcoma–associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element. Blood. 99(2). 649–654. 90 indexed citations
19.
20.
Driggers, Paul H., et al.. (1992). Two upstream elements activate transcription of a major histocompatibility complex class I genein vitro. Nucleic Acids Research. 20(10). 2533–2540. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Faivre Breakdown of academic impact, for papers by Martin Schneider Breakdown of academic impact, for papers by Gauri C. Bedi Breakdown of academic impact, for papers by Huan Yan Breakdown of academic impact, for papers by Yaqin He Breakdown of academic impact, for papers by Steve F. Bronk Breakdown of academic impact, for papers by Nyree Crawford Breakdown of academic impact, for papers by Lydie Gioia‐Patricola Breakdown of academic impact, for papers by Manujendra N. Saha Breakdown of academic impact, for papers by Zhi Ming Shao
Rankless by CCL
2026